Galapagos NV
GLPG
#4956
Rank
$1.86 B
Marketcap
$27.73
Share price
0.00%
Change (1 day)
-3.65%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): $0.55 Billion USD

According to Galapagos NV's latest financial reports the company's current earnings are $1.22 Billion USD. In 2025 the company made an earning of $0.36 Billion USD, an increase over its 2024 earnings that were of -$5.78 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.55 B50.39%
2025 $0.36 B-6464.81%
2024 -$5.78 Million-82.77%
2023 -$33.55 Million-85.59%
2022 -$0.24 Billion60.71%
2021 -$0.15 Billion-60.08%
2020 -$0.37 Billion-331.44%
2019 $0.15 B-523.76%
2018 -$37.01 Million-72.34%
2017 -$0.14 Billion-329.59%
2016 $58.27 M-144.3%
2015 -$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$8.13 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$6.59 B 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$7.65 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$13.15 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$14.66 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$10.01 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-$53.48 Million-109.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$2.27 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel